FDA Inspection 556572 — LEO Pharma Ireland
The FDA completed an inspection of LEO Pharma Ireland on Dec 8, 2008 in Dublin 12. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Dec 8, 2008
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dublin 12 (Ireland)